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OBJECTIVE—The Sec1/Munc18 protein Munc18c has been
implicated in Syntaxin 4–mediated exocytosis events, although
its purpose in exocytosis has remained elusive. Given that
Syntaxin 4 functions in the second phase of glucose-stimulated
insulin secretion (GSIS), we hypothesized that Munc18c would
also be required and sought insight into the possible mecha-
nism(s) using the islet -cell as a model system.
RESEARCH DESIGN AND METHODS—Perifusion analyses
of isolated Munc18c- (/) or Munc18c-depleted (RNAi)
mouse islets were used to assess biphasic secretion. Protein
interaction studies used subcellular fractions and detergent
lysates prepared from MIN6 -cells to determine the mecha-
nistic role of Munc18c in Syntaxin 4 activation and docking/
fusion of vesicle-associated membrane protein (VAMP)2-
containing insulin granules. Electron microscopy was used to
gauge changes in granule localization.
RESULTS—Munc18c (/) islets secreted 60% less insulin
selectively during second-phase GSIS; RNAi-mediated Munc18c
depletion functionally recapitulated this in wild-type and
Munc18c (/) islets in a gene dosage-dependent manner.
Munc18c depletion ablated the glucose-stimulated VAMP2–Syn-
taxin 4 association as well as Syntaxin 4 activation, correlating
with the deﬁcit in insulin release. Remarkably, Munc18c deple-
tion resulted in aberrant granule localization to the plasma
membrane in response to glucose stimulation, consistent with its
selective effect on the second phase of secretion.
CONCLUSIONS—Collectively, these studies demonstrate an
essential positive role for Munc18c in second-phase GSIS and
suggest novel roles for Munc18c in granule localization to the
plasma membrane as well as in triggering Syntaxin 4 accessibility
to VAMP2 at a step preceding vesicle docking/fusion. Diabetes
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umerous recent reports link type 2 diabetes
with single-nucleotide polymorphisms (SNPs)
and reduced abundance of exocytosis proteins
such as soluable N-ethylmaleimide attachment
protein receptor (SNARE) proteins and their regulatory
Munc18 binding partners (1–4). Moreover, several animal
models of insulin resistance and insulin secretory dysfunc-
tion lack normal levels of SNARE proteins (rev. in 5), and
experimental induction of diabetes using streptozotocin
results in loss of expression of SNARE proteins (6). In
contrast, increasing amounts of select SNARE proteins
leads to enhanced insulin sensitivity via increasing glucose
uptake into skeletal muscle as well as enhancing insulin
release in vivo (7,8) and has also been shown to restore
normal insulin secretion in diabetic rodent models (9).
However, alteration of the endogenous level of the regu-
latory protein Munc18c in either direction is implicated
in disrupted glucose homeostasis and type 2 diabetes
(4,10,11), indicating the need for mechanistic clariﬁ-
cation of the role(s) of Munc18c in the exocytotic
processes that govern the maintenance of whole-body
glucose homeostasis.
Biphasic insulin release is believed to be important for
optimal glucose homeostasis. The ﬁrst phase of insulin
release is well studied and known to be triggered by the
entry and metabolism of glucose into the -cell via the
constitutively plasma membrane–localized GLUT2 trans-
porter, leading to a net increase in intracellular ATP-to-
ADP ratio (rev. in 12). This result induces closure of the
ATP-dependent K
 channels and membrane depolariza-
tion, upon which the voltage-dependent calcium channels
open to promote calcium entry (13–15). Calcium entry
triggers fusion of the insulin granules docked/primed in
the readily releasable pool at the plasma membrane via
Syntaxin 1A– and Syntaxin 4–dependent mechanisms
(8,16,17). Immediately after the ﬁrst phase comes a second
and sustained phase of insulin release, which is attributed
to the reﬁlling of the readily releasable pool from more
intracellular insulin granule storage pools (18). The mech-
anisms underlying biphasic insulin secretion have yet to be
fully elucidated, although this biphasic pattern is now
recognized as being conserved among human, rat, and
mouse islets under short-term culture conditions (19–22).
Vesicle exocytosis involves the speciﬁc binding of the
vesicle-associated membrane protein (VAMP) v-SNARE
with a binary cognate receptor t-SNARE complex, com-
posed of SNAP25/23 and Syntaxin proteins, to form the
heterotrimeric SNARE core complex (rev. in 23). Plasma
membrane–localized Syntaxin proteins are further regu-
lated by SM proteins (Sec1/Munc18) that bind with selec-
tivity to their cognate Syntaxins; Munc18a and Munc18b
bind to Syntaxins 1–3, whereas only Munc18c binds to and
regulates Syntaxin 4 in cells (24–27). All three Munc18
isoforms are expressed in islet -cells, although only
Munc18a and Munc18c have been implicated in insulin
release to date (7,8,28). Munc18a RNAi-mediated depletion
was used to establish its positive role in insulin secretion
through Syntaxin 1 (28), with Syntaxin 1 recognized as key
to ﬁrst-phase insulin release but not for second-phase
release (17). Similarly, islets isolated from Munc18c (/)
knockout mice secrete signiﬁcantly less insulin in re-
sponse to glucose stimulation in static culture studies,
contributing to the increased susceptibility of the Munc18c
(/) knockout mice for developing type 2 diabetes (29).
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Syntaxin 4–mediated granule exocytosis and Syntaxin 4
has been shown to be required for both phases of insulin
release (7,8), we hypothesized that Munc18c would func-
tion in at least one of the two phases of insulin release. In
addition, Munc18 proteins have recently been implicated
in binding events with nonsyntaxin proteins, suggesting
that its role in biphasic insulin exocytosis could also be
Syntaxin 4 independent.
In the present study, we investigated the functional and
mechanistic roles of Munc18c in regulating glucose-stim-
ulated biphasic insulin secretion. Islets isolated from
Munc18c (/) heterozygous knockout mice were selec-
tively deﬁcient in second-phase insulin secretion; RNAi-
mediated depletion of endogenous Munc18c in isolated
islets fully recapitulated this defect. Multiple mechanistic
defects associated with Munc18c depletion were revealed
that may cumulatively account for the selective functional
lapse in second-phase insulin release: 1) Munc18c deple-
tion resulted in decreased Syntaxin 4 accessibility to
VAMP2, supporting a role for the plasma membrane pool
of Munc18c in a predocking step involving Syntaxin 4
activation and/or granule capture; 2) Munc18c depletion
resulted in signiﬁcantly fewer granules visibly juxtaposed
to the plasma membrane in electron micrographs, suggest-
ing for the ﬁrst time that the cytosolic pool of Munc18c
may be functionally required for mobilizing granules in
response to glucose stimulation.
RESEARCH DESIGN AND METHODS
Materials. The rabbit polyclonal anti-Munc18c antibody was generated as
described (30). The rabbit Syntaxin 4, mouse clathrin, mouse anti–green
ﬂuorescent protein (GFP), and mouse VAMP2 antibodies were purchased
from Chemicon (Temecula, CA), BD Biosciences (Franklin Lakes, NJ),
Clontech (Mountain View, CA), and Synaptic Systems (Gottingen, Germany),
respectively. Mouse anti-insulin and mouse monoclonal (M2) Flag antibodies
were obtained from Sigma (St. Louis, MO), and the anti-mouse Texas Red
secondary antibody was purchased from Jackson ImmunoResearch Labora-
tories (West Grove, PA), respectively. The MIN6 cells were a gift from Dr.
John Hutton (University of Colorado Health Sciences Center). The sensitive
rat insulin radioimmunoassay kit was acquired from Linco Research (St.
Charles, MO).
Plasmids. Four different pSilencer1.0-siMunc18c constructs were generated
by insertion of annealed double-stranded complementary oligonucleotides
encoding 19 nucleotides (nt) of mouse Munc18c, followed by a loop region
(TTCAAGAGA) and the antisense of the 19 nt. The 19 nt sequences were as
follows: (number 1) 5-ACAGCCGTGTTCGATGACT-3; (number 2) 5-
GCAGCGTATATATACTTCA-3; (number 3) 5-GCAGATCTCGAAGCAAGTA-
3; and (number 4) 5-AGGATCGGTCTGCAGAAGA-3. The pSilencer1.0
control construct (siCon) was generated similarly, using a 19 nt sequence
(GCGCGCTTTGTAGGATTCG) that failed to recognize any other mammalian
protein (31). Oligonucleotides were generated to encode ApaI and EcoRI sites
at the 5 and 3 ends, respectively, for insertion into the pSilencer 1.0-U6
vector (Ambion). The siMunc18c-Ad adenovirus was generated by insertion of
the number 2 siRNA double-stranded complementary oligonucleotide frag-
ment into the 5 AﬂII and 3 SpeI sites of the pMighty vector (Viraquest, North
Liberty, IA). The siCon-Ad was generated similarly in the pMighty vector, as
previously described (31). Each construct was linearized by restriction
digestion with NdeI and packaged with enhanced GFP (EGFP) to enable
visualization of infection efﬁciency.
Cell culture, transient transfection, adenoviral transduction, and insu-
lin secretion. CHO-K1 cells were purchased from the American Type Culture
Collection (Manassas, VA) and cultured in Ham’s F-12 medium supplemented
with 10% fetal bovine serum, 100 U/ml penicillin, 100 g/ml streptomycin, and
292 g/ml L-glutamine. At 50–70% conﬂuence, cells were transfected with 40
g DNA as previously described (32) to obtain 70% efﬁciency. MIN6 -cells
were cultured as described previously (32) and transduced at multiplicities of
infection (MOI)  50–100 for 1 h, washed with PBS, and incubated in MIN6
medium for 48 h. Cells were then preincubated for2hi nglucose-free modiﬁed
Krebs ringer bicarbonate buffer (MKRBB): 5 mmol/l KCl, 120 mmol/l NaCl, 15
mmol/l HEPES, pH 7.4, 24 mmol/l NaHCO3, 1 mmol/l MgCl2, 2 mmol/l CaCl2
and 1 mg/ml BSA, stimulated with 20 mmol/l glucose for 30 min and buffer
collected for quantitation of insulin released. Detergent cell lysates were
prepared by harvesting in 1% Nonidet P-40 lysis buffer (1% NP-40, 25 mmol/l
HEPES, pH 7.4, 10% glycerol, 50 mol/l sodium ﬂuoride, 10 mmol/l sodium
pyrophosphate, 1 mmol/l sodium vanadate, 137 mmol/l sodium chloride, 1
mmol/l phenylmethylsulfonyl ﬂuoride, 1 g/ml pepstatin, and 10 g/ml apro-
tinin) and lysates cleared by microcentrifugation for 10 min at 4°C for use in
immunoprecipitation and immunoblotting. Subcellular fractions were isolated
as previously described (33). All pellets were resuspended in the 1% NP-40
lysis buffer to ensure solubilization of membrane proteins.
Recombinant proteins and interaction assays. The GST-VAMP2 protein
(soluble, TM domain deleted) was generated in Escherichia coli and puriﬁed
by glutathione-agarose afﬁnity chromatography as described previously (34)
for use in the Syntaxin accessibility assay. GST-VAMP2 linked to sepharose
beads was combined with 2 mg detergent cell lysate for2ha t4 ° Ci nNP-40
lysis buffer, followed by three stringent washes with lysis buffer, and associ-
ated proteins were resolved on 12% SDS-PAGE followed by transfer to
polyvinylidene diﬂuoride membrane for immunoblotting.
Mouse islet isolation and perifusion. All studies involving mice followed
the guidelines for the use and care of laboratory animals at the Indiana
University School of Medicine. Munc18c heterozygous (/) knockout mice
have been described previously (29). All wild-type and Munc18c (/) male
mice used in these studies were bred by HETHET crosses from mice
enriched on the C57BL/6J background to at least F16 and littermates used in
paired islet isolations (/ fail to survive beyond E7.5). Pancreatic mouse
islets were isolated as previously described (8), with pancreata of ﬁve mice
combined to generate each batch of islets. Islets were perifused at a ﬂow rate
of 0.3 ml/min for 10 min in KRB HEPES (KRBH) containing 2.8 mmol/l glucose
with eluted fractions captured at 1-min intervals, followed by glucose stimu-
lation (20 mmol/l) for 35 min. Quantitation of area under the curve for ﬁrst-
and second-phase insulin release was performed according to previously
published criteria (35).
Adenoviral transduction of islets. Islets were isolated and immediately
transduced at an MOI  100 (based on assumption of 1,000 cells within each
islet) with either siCon-Ad or siMunc18c-Ad CsCl-puriﬁed particles titered at
3  10
10 and 1  10
10 pfu/ml, respectively, for1ha t37°C in RPMI-1640.
Transduced islets were then washed twice and incubated for 40 h at 37°C/5%
CO2. EGFP ﬂuorescence was visualized in 	95% of outer cells of islets in all
experiments, and similarly ﬂuorescent islets were handpicked for perifusion
analysis.
Co-immunoprecipitation and immunoblotting. For each immunoprecipi-
tation, 2 mg cleared detergent lysates were combined with 2 g of indicated
antibodies and allowed to rotate for2ha t4°C. Protein G Plus agarose beads
were added and reactions rotated at 4°C for an additional 2 h. After three
washes with lysis buffer, the resulting immunoprecipitates were subjected to
12% SDS-PAGE followed by transfer to polyvinylidene diﬂuoride membrane
for immunoblotting and bands visualized by enhanced chemiluminescence
using a Chemi-Doc imaging system (Bio-Rad).
Electron microscopy. MIN6 -cells were grown to 80% conﬂuence on
Thermonox coverslips. Cells were incubated for2hi nfreshly prepared
MKRBB buffer followed by stimulation with 20 mmol/l glucose for 5 min. Cells
were ﬁxed in a 0.1 mol/l cacodylate-buffered mixture of 2% glutaraldehyde and
2% paraformaldehyde for 30 min at room temperature followed by overnight
incubation at 4°C and then postﬁxed in 1% OsO4 for 1 h. En bloc staining in
0.5% aqueous uranyl acetate was performed for 3 h followed by a 10-min water
wash. Dehydration was done in the following sequence: 50% ethanol, 70%
ethanol, 95% ethanol, and 100% ethanol each for 10 min. Inﬁltration entailed
ethanol and resin in the order of 3:1 (1 h), 1:1 (overnight), 1:3 (1 h), and 100%
resin (two to three changes each 30 min). The Thermonox coverslips were
inverted over a 1.5-ml centrifuge tube ﬁlled with resin and polymerized for
48 h at 60°C. Thin (60–100 nm) sections were cut using the microtome (Leica
Ultracut). The thin sections were stained with uranyl acetate and lead citrate
and viewed on the FEI Tecnai G2 Biotwin.
mRNA extraction and quantitative real-time PCR analysis. mRNA from
islets was prepared using Trizol reagent (Invitrogen). mRNA was quantiﬁed by
absorbance at 260 and 280 nm. Reverse transcription was performed using the
Invitrogen SuperScript one-step RT-PCR kit and was done at 50°C for 50 min.
The mRNA level was determined using the ﬂuorescent intercalating dye
SYBR-Green kit and the LightCycler system (RocheApplied Science, Indianap-
olis, IN). RNA (2 g) was used for ﬁrst-strand cDNA synthesis. Primer
sequences for Munc18c were as follows: Munc18c sense, 5- GGACCTG-
GCACTTGGAACAG-3; and antisense, 5-GAGGAGCACCAGCATGGAGT-3.
Glyceraldehyde 3-phosphatase dehydrogenase (GAPDH) was used as an
internal control. The cycle threshold (Ct) value, deﬁned as the PCR cycle at
which a statistically signiﬁcant increase of reporter ﬂuorescence is ﬁrst
detected, was used as a measure for the starting copy numbers of target genes.
The ratio of the Ct value of Munc18c mRNA to that of GAPDH in islets was
determined as the relative Munc18c mRNA level.
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Student’s t test. Data are expressed as the mean 
 SE.
RESULTS
Islets from Munc18c (/) knockout mice exhibit
impaired second-phase insulin secretion. Islets were
isolated from Munc18c (/) or wild-type littermate mice
and perifused to measure insulin secretion every minute
over a 60-min time period to determine which phase of
glucose-stimulated insulin secretion (GSIS) required
Munc18c (Fig. 1A). After an equilibration period of 30 min,
islets were perifused for 10 min in KRBH buffer containing
2.8 mmol/l glucose to establish baseline secretion (basal),
followed by stimulation for 35 min with 20 mmol/l glucose,
FIG. 1. Islets from Munc18c (/) mice have signiﬁcantly impaired second-phase insulin secretion. Islets isolated from wild-type (WT) or
Munc18c (/) mice were handpicked into groups of 50 and layered onto cytodex bead columns for parallel perifusion analysis. A: Islets were
ﬁrst preincubated for 30 min in low glucose (2.8 mmol/l), followed by basal sample collection (1–10 min) at low glucose to establish a baseline.
Glucose was then elevated to 20 mmol/l for 35 min and subsequently returned to low glucose for 15 min. Eluted fractions were collected at 1-min
intervals at a ﬂow rate of 0.3 ml/min and insulin secretion was determined by radioimmunoassay. B: Quantitation of the area under the curve
(AUC) for ﬁrst-phase (11–17 min) and second-phase (18–45 min) insulin secretion from islets isolated from WT and Munc18c (/), normalized
to baseline as described previously (8,35). C: Approximately 150 islets were solubilized in SDS sample buffer and resolved on 12% SDS-PAGE for
immunoblotting (IB). D: Optical density scanning quantitation was used to derive the band density for each WT band, which was used to normalize
that of Munc18c (/) bands in each experiment, and all bands were normalized to Clathrin. Data shown are the average  SE of three to four
independent sets of islets (*P < 0.05). E: Munc18c mRNAs from islets of WT (/) or Munc18c (/) mice were quantitated using real-time PCR.
All Munc18c mRNA levels were normalized to GAPDH. Data represent the mean  SE of three independent sets of islets (*P < 0.05).
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15 min. Wild-type islets exhibited a peak within 5 min of
glucose stimulation, consistent with the occurrence of
ﬁrst-phase insulin secretion. The ﬁrst peak was followed
by a sustained second phase that persisted at a level
greater than threefold above basal level until glucose
levels were reduced back to basal, mimicking insulin
release kinetics previously reported (8,17,19,35). However,
islets from Munc18c (/) mice secreted 60% less
during the second phase, as seen in three independent
batches of perifused islets and quantitated by the area
under the curve analysis according to established criteria
(35), wherein the ﬁrst phase occurs between minutes 11
and 17 and the second phase occurs between minutes 18
and 45 of the perifusion experiment (Fig. 1B). The
Munc18c protein level in islets isolated from Munc18c
(/) was reduced by at least 40% compared with wild-
type islets (Fig. 1C and D), consistent with our previous
observations using whole pancreas tissue extracts (29);
abundances of Syntaxin 4 (Syn4) and VAMP2 were un-
changed (Fig. 1C and D). Quantitative real-time PCR using
RNA prepared from islets showed a speciﬁc loss of 40%
Munc18c mRNA compared with wild type (Fig. 1E; P 
0.05). These data expanded upon previous static incuba-
tion results by showing a selective and essential role for
Munc18c in the second phase of GSIS.
RNAi-mediated depletion of Munc18c recapitulates
the impaired insulin exocytosis phenotype of the
Munc18c (/) mouse islets. RNAi-mediated depletion
was used as an independent approach to assess the
involvement of Munc18c in insulin secretion. Four differ-
ent siRNA constructs were initially generated against
Munc18c and introduced into Chinese hamster ovary
(CHO)-K1 cells using a transient plasmid delivery system
(pSilencer1.0-U6). Because the endogenous Munc18c pro-
tein was undetectable by the anti-Munc18c antibody in
CHO-K1 cells, cells were co-electroporated with Flag-
tagged recombinant Munc18c DNA plus one of the four
different siRNA constructs to examine the capability of
each siRNA to speciﬁcally deplete recombinant Munc18c
protein expression compared with a control siRNA se-
quence (siCon). As seen in Fig. 2A, construct number 2
exerted the greatest reduction (50%), and this siRNA was
subsequently used in an adenoviral expression system to
transduce MIN6 -cells and isolated islets. The efﬁciency
of endogenous siMunc18c-Ad depletion from MIN6 cells
was 55% overall (Fig. 2B), and analysis of Munc18c deple-
tion in plasma membrane and cytosolic fractions showed
50% reduction of Munc18c protein each (data not
shown). This loss of Munc18c protein corresponded to a
50% reduction in insulin release after a 30-min stimulation
with glucose compared with GSIS from siCon-Ad cells
(Fig. 2C). siMunc18c-Ad affected only glucose-stimulated
release (625 
 84 ng/ml for siCon vs. 340 
 20 ng/ml for
siMunc18c, n  3), having no signiﬁcant impact on basal
insulin release (129 
 14 ng/ml for siCon vs. 138 
 11
ng/ml for siMunc18c, n  3) or cellular insulin content
(46,070 
 2,510 ng/ml for siCon vs. 43,780 
 2,000 ng/ml
for siMunc18c, n  3).
In islet perifusion analyses, wild-type islets transduced
with siMunc18c-Ad exhibited signiﬁcant reduction of sec-
ond-phase GSIS compared with siCon-Ad islets, whereas
ﬁrst-phase secretion failed to show a statistically signiﬁ-
cant reduction (Fig. 3A and B). These data validate those
results from our Munc18c (/) islets, supporting an
important positive role for the Munc18c protein in second-
phase insulin granule exocytosis. This validation of our
Munc18c (/) mouse is important given the conﬂicting
exocytosis results obtained using mouse embryonic ﬁbro-
FIG. 2. RNAi-mediated Munc18c depletion recapitulates the loss of function observed in Munc18c (/) islets. A: Four Munc18c shRNA
constructs and a noncoding control construct were each co-electroporated with pcDNA3-ﬂag-Munc18c into CHO-K1 cells and detergent cell
lysates prepared 48 h later to determine the efﬁciency of protein depletion achieved by each. Lysates were subjected to 10% SDS-PAGE for
immunoblotting with anti-Flag and anti-clathrin (loading control) antibodies. Optical density scanning quantitation was used to derive the band
density for each clathrin band, which was used to normalize that of Flag (Munc18c) bands in each experiment, and the mean  SE of at least four
independent sets of islets were determined (*P < 0.05). B: MIN6 cells transduced with siCon or siMunc18c adenoviruses, and after a 48-h
incubation, cell lysates were prepared for use in anti-Munc18c immunoprecipitation and immunoblotting to detect knockdown efﬁciency.
Anti-EGFP immunoblotting was used to indicate transduction efﬁciency and for normalization of Munc18c band densities in greater than three
independent experiments (*P < 0.05). C: After a 48-h incubation following transduction by adenovirus, MIN6 cells were preincubated in MKRBB
for 2 h and either left unstimulated or were stimulated with 20 mmol/l glucose for 30 min. Secreted insulin was measured by radioimmunoassay.
Data shown are the means  SE from three independent experiments (*P < 0.05).
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(36).
To determine if the lack of effect upon ﬁrst-phase insulin
release was due to the heterozygosity of the islets and
mere 40–50% reduction of Munc18c protein, the abun-
dance of Munc18c was further decreased by using
siMunc18c-Ad to deplete Munc18c (/) islets. From
siMunc18c-transduced Munc18c (/) islets, Munc18c
protein expression was reduced by an additional 55%
compared with levels present in the siCon-transduced
Munc18c (/) islets (Fig. 4A and B), cumulatively reduc-
ing the endogenous Munc18c protein content by 75%
compared with wild-type islet Munc18c protein content.
Syntaxin 4 and VAMP2 levels were unaffected by
siMunc18c-Ad transduction (Fig. 4B). When subjected to
islet perifusion analysis, siMunc18c-transduced Munc18c
(/) islets exhibited a signiﬁcant reduction in second-
phase GSIS compared with siCon-transduced Munc18c
(/) islets (Fig. 4C and D) or wild-type islets (red trace).
Comparison of area under the curve calculated as repre-
senting ﬁrst-phase secretion among wild-type (7.0 
 0.3)
nontransduced Munc18c (/) islets (6.0 
 0.6), siCon-
Ad–transduced Munc18c (/) islets (6.6 
 0.6), and
siMunc18c-Ad–transduced Munc18c (/) islets (5.3 

0.7) showed a small effect of Munc18c dosage as well (P 
0.05, wild-type vs. siMunc18c-Ad–transduced Munc18c
(/) islets), albeit the more dramatic defect appeared to
be in the second phase.
Munc18c depletion reduces the number of insulin
granules localized to the plasma membrane. The re-
duction of second-phase GSIS from Munc18c (/)- or
siMunc18c-transduced islets could result from impairment
in one or multiple steps involved: granule mobilization
from internal storage pools to the cell surface, granule
docking/priming, or fusion of the granules with the plasma
membrane. To discriminate between these possible steps,
we began by assessing granule locale by electron micros-
copy within MIN6 cells transduced with siCon-Ad or
siMunc18c-Ad. Because of the paucity of material obtain-
able from primary islet cells, MIN6 cells were used as a
model system for mechanistic studies because they fully
recapitulated the requirement for Munc18c in GSIS and are
considered to be one of the clonal lines that has retained
some level of biphasic secretion. Granule location with
respect to distance from the plasma membrane was tabu-
lated for each condition (siCon versus siMunc18c under
basal and glucose-stimulated conditions) and grouped into
one of three categories: localized within 50 nm, between
50 and 300 nm, or 	300 nm from the plasma membrane.
Granules located in the 50-nm group have been termed
“morphologically docked” in the literature (18). Criteria
for counting included the visualization of viral particles as
conﬁrmation of transduction and presence of the plasma
membrane and of the nucleus in each ﬁeld. Granule
mobilization to the plasma membrane in MIN6 cells be-
comes evident as early as 5 min after glucose stimulation
(34), consistent with the reported onset of a second phase
beginning after 6 min in this cell line and also with the
concept that mobilization events must begin during the
ﬁrst phase to sustain secretion. As shown in Fig. 5A,
granules juxtaposed to the plasma membrane were clearly
visible in the siCon-transduced cells that had been stimu-
lated with glucose for 5 min compared with unstimulated/
basal (Fig. 5A, panels 1 and 2); this was similar in
micrographs prepared from cells stimulated for either 5 or
30 min (Fig. 5A, panels 2 and 3). In contrast, glucose-
stimulated siMunc18c-Ad–transduced cells contained sig-
niﬁcantly fewer granules within the 50-nm range (Fig. 5A,
panels 5 and 6, and B), although the total number of
granules within each ﬁeld of siCon-Ad and siMunc18c-Ad
cells was similar (Fig. 5C). Analysis of granules in the
more distant categories showed that in siMunc18c-Ad
cells, a signiﬁcant proportion of total granules remained
	300 nm from the plasma membrane, even after glucose
stimulation. Interestingly, there were no observable differ-
ences in granule proximity to the plasma membrane in
unstimulated siCon-Ad or siMunc18c-Ad cells (Fig. 5A,
panel 1 vs. 4, and B). These data suggested that glucose-
induced granule movement toward the plasma membrane
in Munc18c-depleted cells was reduced and could repre-
sent a mechanism by which to explain the deﬁcit in
second-phase GSIS.
Munc18c depletion disrupts Syntaxin 4’s activation
and association with VAMP2. The reduction in granule
number in close proximity to the plasma membrane in
glucose-stimulated siMunc18c-transduced cells could have
resulted from a failure of the granules to be retained at the
plasma membrane via docking with Syntaxin 4 and/or of
their failure to progress toward the plasma membrane. To
test the ﬁrst possibility, that Munc18c depletion impaired
FIG. 3. RNAi-mediated depletion of Munc18c from MIN6 cells inhibits
glucose-stimulated insulin release.A : Islets freshly isolated from
wild-type (WT) mice were immediately transduced with siCon-Ad or
siMunc18c-Ad adenovirus for 1 h, after which islets were washed and
incubated for 40 h in RPMI medium. Evenly transduced GFP
 islets
were handpicked under a ﬂuorescence microscope into groups of 50
and layered onto cytodex bead columns for paired (siCon versus
siMunc18c) perifusion analyses, as described in Fig. 1. Data represent
the mean  SE for three independent perifusion studies using different
islet preparations (*P < 0.05). B: Quantitation of the area under the
curve (AUC) for ﬁrst-phase (11–17 min) and second-phase (18–45
min) insulin secretion from WT islets transduced with siCon-Ad and
siMunc18c-Ad. Data represent the mean  SE for three independent
experiments (*P < 0.05).
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Syntaxin 4 at the plasma membrane, MIN6 cells were
adenovirally transduced and detergent lysates of plasma
membrane fractions (Fig. 6A) or cleared detergent cell
lysates (Fig. 6B) prepared there from were used in anti–
Syntaxin 4 immunoprecipitation reactions. Glucose stim-
ulated a 1.8-fold increase in VAMP2 association with
Syntaxin 4 in plasma membrane fractions prepared from
siCon cells (Fig. 6A); no increase was seen in fractions
from siMunc18c cells. Anti–Syntaxin 4 co-immunoprecipi-
tated 50% less Munc18c protein from siMunc18c-Ad
plasma membrane fractions, consistent with the 50%
reduction of Munc18c protein from the plasma membrane
compartment. Similar results were obtained using cleared
detergent cell lysates prepared from siCon-Ad– or
siMunc18c-Ad–transduced MIN6 cells (Fig. 6B); the glu-
cose-stimulated increase in VAMP2–Syntaxin 4 association
was only observed in siCon-treated lysates and not in
siMunc18c-treated lysates (Fig. 6B). These data supported
the notion that Munc18c was necessary for the glucose-
induced steps at the plasma membrane that precede
docking and/or fusion, although this assay cannot distin-
guish between effects upon docking (trans-SNARE com-
plexes) versus fusion (cis-SNARE complexes).
To distinguish whether Munc18c was required to
facilitate a glucose-induced increase in the Syntaxin 4
accessibility to VAMP2 docking, exogenous GST-VAMP2
(soluble form) protein linked to sepharose beads was
added to cleared detergent cell lysates to “probe” for
accessible Syntaxin 4, i.e., Syntaxin 4 that was available
for binding. From siCon-transduced MIN6 cells stimu-
lated with glucose, the GST-VAMP2 was able to co-
precipitate signiﬁcantly more Syntaxin 4 protein
compared with that from unstimulated cells (Fig. 7A and
B). In contrast, siMunc18c–transduced cell lysates
lacked this glucose-stimulated increase in Syntaxin 4
association with GST-VAMP2. Syntaxin 4 immunoblot-
ting of lysate input indicated lack of effect of siRNA
adenoviral expression or of glucose treatment upon
Syntaxin 4 protein abundance (Fig. 7A, lanes 1–4).
Anti-GST immunoblotting indicated that equal levels of
GST-VAMP2 protein were precipitated (Fig. 7A, lanes
5–8). Thus, these results suggested that Munc18c
played an essential role in transitioning Syntaxin 4 into
a more accessible conformation for its subsequent
docking with VAMP2 in response to the glucose
stimulus.
FIG. 4. Dose-dependent depletion of Munc18c corresponds to graded reduction of second-phase insulin release. Islets were isolated from Munc18c
(/) mice and immediately transduced at MOI  100 with siCon-Ad or siMunc18c-Ad for1ha t37°C. Islets were cultured for 40 h, after which
GFP-expressing islets were handpicked under a ﬂuorescent microscope for Western blot analysis (A) and optical density scanning thereof to
determine level of knockdown (B), and for perifusion analysis (C), as described previously in Fig. 1A. Data represent the mean  SE of three
independent perifusion studies using different islet preparations (*P < 0.05). A trace from wild-type islets (red line) transduced with siCon-Ad
is shown for comparison purposes. Quantitation of the area under the curve (AUC) for ﬁrst-phase (11–17 min) and second-phase (18–45 min)
insulin secretion from islets transduced with siCon-Ad and siMunc18c-Ad, normalized to baseline, is shown. Data represent the mean  SE for
three independent experiments (*P < 0.05 vs. siCon-Ad). IB, immunoblotting. (A high-quality digital representation of this ﬁgure is available in
the online issue.)
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FIG. 5. Munc18c depletion alters insulin granule distribution. A: Trans-
mission electron microscopy of MIN6 cells transduced with siCon-Ad
(panels 1–3) or siMunc18c-Ad (panels 4–6) adenoviral particles. Cells
were incubated for 48 h and then placed in glucose-free MKRBB for 2 h
and subsequently stimulated with 20 mmol/l glucose (Gluc) for 5 min
(panels 2 and 5)o r3 0m i n( panels 3 and 6), or left unstimulated (basal,
panels 1 and 4) and ﬁxed for electron microscopy as described in
RESEARCH DESIGN AND METHODS. Arrows indicate the presence of viral
particles; arrowheads denote the plasma membrane. Bar  500 nm. B:
Distribution of insulin granules in siCon-Ad– and siMunc18c-Ad–trans-
duced cells. Criteria for inclusion were presence of viral particles, clear
demarcation of the plasma membrane, and presence of nucleus in each
ﬁeld tabulated. Insulin granule distance from the plasma membrane was
tabulated for siCon and siMunc18c electron micrographs from 48 ran-
domly selected MIN6 cells, with a total of 1,063 granule distances
measured and grouped into categories based on the distance from the
plasma membrane (*P < 0.05 vs. siCon-Ad). C: Total granule number per
ﬁeld/section in siCon-Ad–and siMunc18c-Ad–transduced cells under each
condition was quantiﬁed.
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In a previous study, Munc18c heterozygous (/) mouse
islets were found to exhibit signiﬁcantly impaired GSIS
under static incubation conditions (29), although the
phase affected and the underlying mechanistic defect was
undetermined. In this follow-up study, Munc18c protein
was found to function selectively in the second phase of
GSIS, also referred to as the mobilization phase. In agree-
ment with this ﬁnding, our electron microscopy studies
revealed a novel requirement for Munc18c in the glucose-
mediated mobilization toward/retention of granules at the
plasma membrane. Consistent with a role in capture/
retention of granules at the plasma membrane, Munc18c
was found to be key in facilitating the glucose-stimulated
“activation” of Syntaxin, to increase its accessibility to
VAMP2. Taken together, these data suggest new positive
roles for Munc18c in predocking events that may underlie
its requirement in the second phase of GSIS.
To the best of our knowledge, this is the ﬁrst report to
differentiate the need for an SM protein such as Munc18c
in Syntaxin 4 accessibility, a step we refer to as “Syntaxin
4 activation,” from other steps such as vesicle capture
(tethering)/docking/fusion. For example, it has recently
been shown that depletion of the Munc18a isoform from
INS-1 cells reduces both GSIS and KCl-stimulated secre-
tion from INS-1 cells coordinate with reducing the number
of granules present in the total internal reﬂection ﬂuores-
cent microscopy (TIRFM) zone at the plasma membrane.
Based on this, it was concluded that the role of Munc18a
was in vesicle tethering/docking. Similarly, both Munc18a
and the nematode SM protein unc-18 are labeled as
docking factors, since their depletion from their respective
cell types reduced the number of docked release-ready
vesicles at the plasma membrane (37–39). Interestingly,
the SM protein Vps45 was shown to be required for
t-SNARE participation in SNARE complexes (40), but as
FIG. 6. Munc18c depletion correlates with decreased Syntaxin
4–VAMP2 association. MIN6 cells transduced with siCon-Ad or
siMunc18c-Ad were placed in glucose-free MKRBB for 2 h for subse-
quent stimulation with 20 mmol/l glucose for 5 min and immediately
subjected to subcellular fractionation to obtain plasma membrane
fractions (A) or detergent lysis to obtain cleared detergent cell lysates
for subsequent use in anti–Syntaxin 4 immunoprecipitation (IP) reac-
tions (B). Immunoprecipitated proteins were resolved on 12% SDS-
PAGE for immunodetection of Munc18c, Syntaxin 4 (Syn4), and
VAMP2. Data represent the mean  SE of three to ﬁve independent
sets of fractions or lysates. *P < 0.05 vs. siCon-Ad. Gluc, glucose; IB,
immunoblotting.
FIG. 7. Depletion of Munc18c decreases Syntaxin 4 accessibility to
VAMP2. Detergent cell lysates prepared from MIN6 cells transduced
with siCon-Ad or siMunc18c-Ad were incubated with puriﬁed GST-
VAMP2 linked to beads. GST-VAMP2 and associated proteins were
subjected to 12% SDS-PAGE for immunoblotting (IB) with anti–
Syntaxin 4 (Syn4) antibody. Anti-GST immunoblotting shows equal
loading of GST-VAMP2. Data represent the mean  SE of ﬁve indepen-
dent sets of lysates (*P < 0.05). Gluc, glucose.
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distinguished from effects upon mobilization. Given that
the only role for SM proteins to date is related to their rich
abundance at the plasma membrane (to which they asso-
ciate in large part due to their high-afﬁnity binding to their
cognate Syntaxin partners), declaring the role(s) of the SM
proteins to be at the plasma membrane is reasonable. Our
data are consistent with these examples, but clearly dis-
tinguished this new mechanistic role for Munc18c in
Syntaxin 4 activation in particular because the assay used
was not confounded by differential granule abundance at
the plasma membrane.
Even with our demonstration for a clearly deﬁned role
for Munc18c at the plasma membrane in Syntaxin 4
activation, there are several reasons why Munc18c may
also be involved in granule mobilization. First, 50% of
cellular Munc18c resides in the cytosolic compartment in
the absence of Syntaxin 4, yet its function in this compart-
ment remains unknown (8). Second, the exocytosis events
in which Munc18c is required, i.e., second-phase GSIS and
insulin-stimulated GLUT4 vesicle translocation, are rela-
tively slow and sustained events compared with the rapid
synaptic vesicle exocytosis and ﬁrst-phase insulin release
events that require Munc18a. Third, second-phase GSIS
and insulin-stimulated GLUT4 vesicle translocation in-
volve relatively long-distance granule mobilization events,
compared with the short-range docked-primed transition
event or the docking of granules already present in the
plasma membrane–localized readily releasable pool to
support ﬁrst-phase insulin release or rapid neurotransmit-
ter release. Fourth, Munc18c depletion failed to affect
granule distribution in unstimulated cells, consistent with
its lack of effect on ﬁrst-phase secretion, which has been
shown to be supported by the release of granules from the
readily releasable pool at the plasma membrane (18). Our
electron microscopy studies revealed that in Munc18c-
depleted cells, the majority of granules remained furthest
from the plasma membrane after either 5 or 30 min of
glucose stimulation, rather than showing enrichment in
the 50- to 300-nm pool. While it is intriguing to suggest
that granules were not mobilized from the deeper
storage pools of the cell, one cannot exclude testing the
possibility that in the absence of adequate Munc18c
levels at the plasma membrane, granules mobilized to
the plasma membrane then “bounced” and reentered the
more distal granule storage pools. Indeed, a reduced
retention time of vesicles was noted in Munc18a null
chromafﬁn cells (41).
Although Syntaxin 1A is required for only one phase of
insulin release (17), Syntaxin 4 facilitates both phases of
insulin secretion (8), and, as such, we had initially pre-
dicted that Munc18c would also be required for both
phases. This discrepancy could be explained in two ways:
1) ﬁrst-phase secretion is elicited from predocked gran-
ules, so the need for Syntaxin 4 activation or granule
mobilization was alleviated; and 2) the reminiscent
25% of Munc18c protein in the Munc18c (/) 
siMunc18c-Ad islets was sufﬁcient to activate that quotient
of Syntaxin 4 required for the ﬁrst phase, since exocytotic
events of ﬁrst phase are shared with Syntaxin 1 and its
cognate Munc18a protein. Whereas the second possibility
will require a -cell–speciﬁc null Munc18c knockout
model to obtain nearly full Munc18c depletion to assess its
requirement in ﬁrst-phase insulin release, the ﬁrst possi-
bility mentioned above is certainly compatible with the
current concept of vesicle docking.
Other proposed mechanisms for SM proteins have in-
cluded chaperoning Syntaxin to the plasma membrane
(40) as well as in bridging Syntaxin-VAMP2 interactions
directly. However, our data here showed that Syntaxin 4
abundance at the plasma membrane was unimpaired in
cells depleted of Munc18c, and we and others have
previously shown that heteromeric Munc18c-Syntaxin
4–VAMP2 complexes are undetectable in cell and tissue
lysates (34,42). Nevertheless, the studies presented here
aimed to test the proposed mechanism for SM proteins in
transitioning their cognate syntaxins to an “open” state
that is more accessible to the other SNARE proteins to
promote SNARE core complex assembly (rev. in 23). The
present studies support this model, which we and others
have proposed to involve stimulus (glucose)-induced
tyrosine phosphorylation of Munc18c and additional par-
ticipation of non-SNARE factors to elicit transient confor-
mational changes in Syntaxin 4 (32,34,43,44).
Factors such as Doc2, RalA-GTPase, and Munc13-1
have been implicated in biphasic insulin release. For
example, RalA depletion in mouse -cells inhibited both
phases of insulin release, attributed to insufﬁcient readily
releasable pool size as well as defective granule mobiliza-
tion to support second-phase exocytosis (45). Munc13-1
was shown to be required for the sustained release of
insulin upon prolonged stimulation (46). Munc13-1 can
bind to a discrete NH2-terminal domain of Doc2, and
Doc2 can bind to Munc18a and Munc18c through its C2A
and C2B domains, respectively (47,48). In islet -cells,
Doc2 preferentially binds to the tyrosine-phosphorylated
form of Munc18c (34). Furthermore, glucose-stimulated
tyrosine phosphorylation of Munc18c correlates with its
transient dissociation from Syntaxin 4 (32), although
whether this transient dissociation induces the conforma-
tional change in Syntaxin 4 to increase accessibility to
VAMP2 remains to be determined. Lastly, serine/threonine
phosphorylation of Munc18c has also been shown to
induce dissociation of Munc18c from Syntaxin 4 in pan-
creatic acinar cells (49), and this is somewhat analogous
to the protein kinase C–induced serine/threonine phos-
phorylation of Munc18a and its dissociation from Syntaxin
1A (50). Given these ﬁndings for Munc18a and those
presented here for Munc18c, future investigations will be
required to determine if Munc18a and Munc18c actions
work in concert to control biphasic insulin secretion.
Given that novel drug targets will be required to improve
exocytotic function in islet -cells and in skeletal muscle
cells of type 2 diabetic patients, our data showing conser-
vation of Munc18c function between exocytotic mecha-
nisms in these two tissue types may point to Munc18c or
its novel accessory proteins as new and potentially attrac-
tive targets.
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